Overview
Homocysteine is a sulfur-containing amino acid that acts as an intermediate in the biochemical conversion of methionine to cysteine, a process known as trans-sulfuration. Methionine is an essential amino acid derived mainly from animal protein, and homocysteine is produced during normal methylation metabolism. It is never obtained directly from the diet.
To conserve methionine, homocysteine is recycled through a remethylation pathway that requires folic acid, vitamin B6, and vitamin B12. In the bloodstream, homocysteine exists in multiple forms, including free, protein-bound, and disulfide-linked forms. Proper regulation of homocysteine levels is essential for normal metabolic, neurological, and cardiovascular function. Homocysteine
Functions
Homocysteine plays a central role in methylation reactions. It donates methyl groups required for the synthesis of DNA, RNA, and neurotransmitters such as serotonin, dopamine, and norepinephrine. These processes are essential for normal cellular function and nervous system activity.
It also contributes to sulfur metabolism by supporting the synthesis of glutathione, a major intracellular antioxidant that protects cells from oxidative stress and free radical damage. Adequate folate and vitamin B12 levels are essential for this metabolic balance, as deficiencies lead to the accumulation of homocysteine.
Elevated homocysteine levels are associated with neurological effects, including cognitive impairment and neurodegenerative diseases such as Alzheimer’s disease and dementia. From a cardiovascular perspective, raised homocysteine is linked to coronary artery disease, peripheral artery disease, and stroke.
Pathophysiology
Homocysteine is a metabolic intermediate, and disruption in its metabolism results in abnormal accumulation. Functional deficiency of folic acid, vitamin B6, or vitamin B12 leads to impaired remethylation or trans-sulfuration, causing homocysteine levels to rise.
Elevated homocysteine is considered an independent risk factor for cardiovascular diseases, including myocardial infarction, stroke, and peripheral vascular disease. It contributes to endothelial dysfunction, oxidative stress, and prothrombotic states.
Symptoms
Homocysteine abnormalities do not produce symptoms directly but contribute to systemic disease processes. Reduced homocysteine levels have been associated with mood disturbances, depression, delayed wound healing, and neurodegenerative disorders.
Elevated homocysteine levels are associated with cognitive impairment, cardiovascular disease, osteoporosis, macular degeneration, and neurodegenerative conditions. In pregnancy, high homocysteine increases the risk of preeclampsia, gestational hypertension, miscarriage, and preterm birth.
Causes
Low homocysteine levels may result from excess intake of folate, vitamin B6, or vitamin B12, as well as from severe liver disease or low methionine intake due to malnutrition or strict vegan diets. Certain drug therapies, such as betaine used in homocystinuria, may also reduce levels.
High homocysteine levels are caused by genetic factors such as MTHFR mutations and cystathionine β-synthase deficiency. Nutritional deficiencies of folate, vitamin B12, and vitamin B6 are common causes. Medical conditions, including chronic kidney disease, hypothyroidism, diabetes mellitus, and psoriasis, also contribute.
Drug-related causes include methotrexate, phenytoin, carbamazepine, and theophylline. Lifestyle factors such as smoking, excess alcohol intake, high coffee consumption, and sedentary habits further elevate homocysteine levels. Aging, male sex, and pregnancy-related complications are additional contributing factors.
Risk Factors
Individuals with vitamin deficiencies, chronic kidney disease, cardiovascular disease, or genetic metabolic disorders are at higher risk of abnormal homocysteine levels. Smokers, elderly individuals, and those with sedentary lifestyles also face increased risk.
Pregnant women with elevated homocysteine levels represent a high-risk group due to the association with adverse pregnancy outcomes and congenital defects such as neural tube defects.
Indications for Testing
Homocysteine estimation is indicated when vitamin B12 or folate deficiency is suspected, especially in patients presenting with depression, gastrointestinal symptoms, or neuropathy. It is also used in patients with stroke, myocardial infarction, and coronary artery disease.
The test is useful for assessing cardiovascular risk, monitoring vitamin deficiency treatment, and evaluating conditions that affect homocysteine metabolism.
Methods of Estimation and Sample Collection
Homocysteine can be measured using high-performance liquid chromatography, ELISA, mass spectrometry, and immunoassay techniques.
For optimal results, fasting for 8–10 hours is recommended. Patients should avoid alcohol, smoking, strenuous exercise, and medications that interfere with results before testing. Blood is collected in EDTA tubes, kept on ice, and plasma is separated within 30 minutes to prevent artificial elevation.
Interpretation and Reference Range
Normal plasma homocysteine levels range from 5 to 15 µmol/L. Levels between 16 and 30 µmol/L indicate mild elevation, 31 to 100 µmol/L moderate elevation, and values above 100 µmol/L severe hyperhomocysteinemia.
Interpretation should always be done in conjunction with clinical findings and vitamin status.
Limitations
Homocysteine testing has poor specificity and variable results across laboratories. Predictive value is limited, and interpretation is challenging due to lack of universally accepted cutoff values. Treatment effects are not always clear-cut.
